Efficacy of methotrexate treatment in extrauterine pregnancies defined by stable or increasing human chorionic gonadotropin concentrations

Fertility and Sterility

Volumn 77, Issue 4, 2002, Pages 761-765

  Gamzu, Ronni ^a   Almog, Benny ^a   Levin, Yishai ^a   Avni, Amiram ^a   Jaffa, Ariel ^a   Lessing, Joseph B ^a   Baram, Amiram ^a  

^a LIS MATERNITY HOSPITAL   (Israel)

Author keywords

Ectopic pregnancy; Methotrexate

Indexed keywords

CHORIONIC GONADOTROPIN; METHOTREXATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; ECTOPIC PREGNANCY; FEMALE; HUMAN; PRIORITY JOURNAL; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME; BLOOD; COHORT ANALYSIS; ECHOGRAPHY; PREGNANCY; PROSPECTIVE STUDY;

CHORIONIC GONADOTROPIN; COHORT STUDIES; FEMALE; HUMANS; METHOTREXATE; PREGNANCY; PREGNANCY, ECTOPIC; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0036009810     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(01)03256-3     Document Type: Article

References (8)

1. Single-dose methotrexate for treatment of ectopic pregnancy
2. Nonsurgical treatment of ectopic pregnancy
3. Medical management of ectopic pregnancy
4. Interventions for tubal ectopic pregnancy
5. Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies
6. Expectant management of ectopic pregnancy
7. ACOG issues report on the medical management of tubal pregnancy
8. Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy. Part II. Patient preferences for systemic methotrexate